Get notified when EUDA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Auditor's report includes substantial doubt about the company's ability to continue as a going concern.
- Material Weakness (new) — Company previously identified material weaknesses in internal control over financial reporting.
- Resale Overhang (new) — Selling shareholders hold 91.1% of outstanding shares, creating significant potential selling pressure.
- Insider Sale (new) — Former CEO James Tan is selling 6.65 million shares, representing 27.0% of ordinary shares.
- Customer Concentration (new) — Company has high concentration risk on corporate clients, which represent a significant portion of revenue.
EUDA Health Holdings files resale prospectus for up to 22.4M shares and 292K warrants by selling shareholders; company receives no proceeds
Filed September 22, 2023 · ~1 min read
Key Changes
-
high
This is a secondary offering: EUDA is not selling any shares and will not receive proceeds from sales by selling shareholders.
Use of Proceeds verify on EDGAR → -
high
Selling shareholders include former CEO James Tan (6.65M shares, 27.0%) and Watermark Developments (9.66M shares, 39.2%).
Selling Stockholders view on EDGAR → -
high
Resale securities represent approximately 91.1% of total shares outstanding, creating significant overhang.
Risk Factors verify on EDGAR →
4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade EUDA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify